Keywords

• Cyclophosphamide
• Cyclophosphamide powder
• 99% Cyclophosphamide

Quick Details

• ProName: cas 50-18-0 Cyclophosphamide powder
• CasNo: 50-18-0
• Molecular Formula: C7H15Cl2N2O2P
• Appearance: white
• Application: anti cancer
• DeliveryTime: 7-10 days
• PackAge: drum
• Port: Shanghai/Wuhan
• ProductionCapacity: 1000 Kilogram/Day
• Purity: 99
• Storage: room
• LimitNum: 10 Gram

Superiority

Product Name:    Cyclophosphamide
CAS:    50-18-0
MF:    C7H15Cl2N2O2P
MW:    261.09
EINECS:    200-015-4
Melting point     41-45°C
Boiling point     336.1±52.0 °C(Predicted)
density     1.33±0.1 g/cm3(Predicted)
storage temp.     Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
pka    2.84±0.20(Predicted)
form     solid
Water Solubility     Soluble. 1-5 g/100 mL at 23 ºC
Stability:    Stable, but light sensitive. Incompatible with oxidizing agents.

Details

What is Cyclophosphamide
Cyclophosphamide is one of the most successful anticancer agents ever synthesized. Even today, 50 years after its synthesis, cyclophosphamide is still widely used as a chemotherapeutic agent and in the mobilization and conditioning regimens for blood and marrow trans plantation (BMT). Among 1,000 selected compounds and antibiotics tested against 33 tumors, cyclophosphamide was the most effective molecule. The initial clinical trials[1, 2] of cyclophosphamide for the treatment of cancer were performed in 1958, and in 1959 it became the eighth cytotoxic anticancer agent approved by the FDA. It is also approved for minimal change disease of the kidney in children (a disease that causes nephrotic syndrome), but despite its widespread use in other autoimmune disorders and BMT, it has never been approved for these indications.